Pulsed estrogen therapy: pharmacokinetics of intranasal 17-beta-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulations

[1]  Kiyoshi Yamaoka,et al.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations , 1978, Journal of Pharmacokinetics and Biopharmaceutics.

[2]  H. Lévesque.  Efficacy and acceptability of intranasal 17 beta-estradiol for menopausal symptoms: randomised dose-response study , 2000 .

[3]  C. Christiansen,et al.  Efficacy and acceptability of intranasal 17 β-oestradiol for menopausal symptoms: randomised dose-response study , 1999, The Lancet.

[4]  R. Lindsay,et al.  Estrogens and antiestrogens : basic and clinical aspects , 1997 .

[5]  J. Marty.  Menorest: technical development and pharmacokinetic profile. , 1996, European journal of obstetrics, gynecology, and reproductive biology.

[6]  J. Marty.  New trends in transdermal technologies: development of the skin patch, Menorest. , 1996, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[7]  L. Botta,et al.  Bioavailability of estradiol from a new matrix and a conventional reservoir-type transdermal therapeutic system , 1996, European Journal of Clinical Pharmacology.

[8]  G A Colditz,et al.  Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. , 1995, Journal of the National Cancer Institute.

[9]  V. John,et al.  Pharmacokinetic Characterisation of Transdermal Delivery Systems , 1994, Clinical pharmacokinetics.

[10]  C. Gansau,et al.  Pharmacokinetics of estradiol, free and total estrone, in young women following single intravenous and oral administration of 17 beta-estradiol. , 1993, Arzneimittel-Forschung.

[11]  Lobo Ra,et al.  Pharmacokinetics of oral 17 beta-estradiol. , 1992 .

[12]  F. Merkus,et al.  Intranasal estradiol administration to oophorectomized women. , 1991, European journal of obstetrics, gynecology, and reproductive biology.

[13]  C. Anderson,et al.  Pharmacokinetics of percutaneous estradiol: A crossover study using a gel and a transdermal system in comparison with oral micronized estradiol , 1991, Obstetrics and gynecology.

[14]  Fredi Kronenberg,et al.  Hot Flashes: Epidemiology and Physiologya , 1990, Annals of the New York Academy of Sciences.

[15]  E. McBurney,et al.  Contact dermatitis to transdermal estradiol system. , 1989, Journal of the American Academy of Dermatology.

[16]  M. Peacock,et al.  COMPARISON OF THE EFFECTS OF ORAL AND TRANSDERMAL OESTRADIOL ADMINISTRATION ON OESTROGEN METABOLISM, PROTEIN SYNTHESIS, GONADOTROPHIN RELEASE, BONE TURNOVER AND CLIMACTERIC SYMPTOMS IN POSTMENOPAUSAL WOMEN , 1989, Clinical endocrinology.

[17]  R. W. Lievertz.  Pharmacology and pharmacokinetics of estrogens. , 1987, American journal of obstetrics and gynecology.

[18]  H. Judd.  Oestrogen replacement therapy: physiological considerations and new applications. , 1987, Bailliere's clinical endocrinology and metabolism.

[19]  H. Judd,et al.  Treatment of hot flashes with transdermal estradiol administration. , 1985, The Journal of clinical endocrinology and metabolism.

[20]  M. Christensen,et al.  Bioavailability of oestradiol and oestriol administered orally to oophorectomized women. , 1981, Maturitas.

[21]  J. Elber.  Immunological methods in steroid determination: Edited by F. G. Peron and B. W. Caldwell. Appleton-Century-Crofts, 1971. 232 pp $12.50 , 1972 .

[22]  B. Caldwell,et al.  Immunologic Methods in Steroid Determination , 1970, Springer US.